Merck profit soars 61.5 percent as Keytruda sales surge

(Reuters) - Merck & Co Inc reported a 61.5 percent jump in quarterly profit on Friday as demand jumped for its key immuno-oncology drug, Keytruda.

Merck profit soars 61.5 percent as Keytruda sales surge
Read More


Bagikan Berita Ini